Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.06 AUD | -11.76% | -6.25% | -15.49% |
04-04 | Noxopharm Receives AU$100,000 to Progress Brain Cancer Drug | MT |
02-27 | Noxopharm Narrows Fiscal H1 Net Loss Despite Lower R&D Tax Incentive | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-15.49% | 12.91M | |
-3.93% | 86.16B | |
+2.76% | 40.17B | |
-17.51% | 31.47B | |
+54.44% | 25.24B | |
-12.82% | 15.82B | |
-9.12% | 11.96B | |
-15.42% | 11.89B | |
-42.56% | 11.61B | |
+4.87% | 8.84B |
- Stock Market
- Equities
- NOX Stock
- News Noxopharm Limited
- Noxopharm Advances to the Efficacy Portion of its Phase 2 Prostate Cancer Trial